| # | Drug | Count |
|---|---|---|
| 0 | AFLIBERCEPT | 274 |
| 1 | RANIBIZUMAB | 198 |
| 2 | PENTOSAN POLYSULFATE SODIUM | 141 |
| 3 | BEVACIZUMAB | 112 |
| 4 | ASPIRIN | 72 |
| 5 | FARICIMAB | 72 |
| 6 | ASPIRIN 325 MG | 71 |
| 7 | ASPIRIN 81 MG | 71 |
| 8 | PEGCETACOPLAN | 66 |
| 9 | OMEPRAZOLE MAGNESIUM | 65 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PEGCETACOPLAN | 66 | 0.0348 |
| 1 | PENTOSAN POLYSULFATE SODIUM | 141 | 0.0203 |
| 2 | BROLUCIZUMAB | 62 | 0.0170 |
| 3 | AFLIBERCEPT | 274 | 0.0087 |
| 4 | FARICIMAB | 72 | 0.0081 |
| 5 | RANIBIZUMAB | 198 | 0.0075 |
| 6 | CARBOXYMETHYLCELLULOSE SODIUM | 14 | 0.0025 |
| 7 | POVIDONE-IODINE | 8 | 0.0019 |
| 8 | ERGOCALCIFEROL | 51 | 0.0017 |
| 9 | BEVACIZUMAB-AWWB | 7 | 0.0015 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 506 | 0.0027 |
| 1 | Guanylate Cyclase-C Agonist [EPC] | 5 | 0.0024 |
| 2 | Antiseptic [EPC] | 8 | 0.0018 |
| 3 | Photoenhancer [EPC] | 7 | 0.0018 |
| 4 | Provitamin D2 Compound [EPC] | 51 | 0.0017 |
| 5 | CD38-directed Cytolytic Antibody [EPC] | 9 | 0.0015 |
| 6 | alpha-1 Adrenergic Agonist [EPC] | 6 | 0.0014 |
| 7 | Complement Inhibitor [EPC] | 68 | 0.0012 |
| 8 | Plasma Volume Expander [EPC] | 3 | 0.0010 |
| 9 | Amyloid Beta-directed Antibody [EPC] | 2 | 0.0005 |